You just read:

Zavante Therapeutics Presents Additional Clinical And Microbiologic Data From ZOLYD™ Phase 2/3 Trial At ID Week 2017

News provided by

Zavante Therapeutics, Inc.

Oct 04, 2017, 08:00 ET